Pioneering CJD treatment to be tested in patient for the first time

A pioneering treatment, developed by researchers at the Medical Research Council (MRC) Prion Unit at University College London (UK), is to be given to a patient with Creutzfeldt-Jakob disease (CJD) for the first time.

CJD currently has no treatment; it is always fatal and most patients have a rapid decline, with mortalities often occurring just 6 weeks after diagnosis.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.


Leave A Comment